Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

ACC raises red flags over telehealth, payment reform and the cardiologist shortage
"We need telehealth the way we had it for COVID," Cathie Biga told Cardiovascular Business at TCT 2025. "We don't want to go back to having it so restricted."
Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly
Pfizer was all set to acquire New York City-based Metsera for $4.9 billion, but Novo Nordisk stepped in with an unexpected counteroffer of $6.5 billion. Both companies hope to add Metsera's drugs to their GLP-1 portfolios.
Rural hospital switches radiology providers to address lagging wait times
Hillsdale Hospital has entered an agreement with Kalamazoo, Michigan-based Premier Radiology, with the new arrangement starting Oct. 21.
Private equity-backed Medline files for IPO
The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.
Medical malpractice reforms appear to curb unnecessary imaging in ED
State caps on malpractice damages were associated with a roughly 21% decrease in low-value imaging use for headaches, according to new Neiman Policy Institute research.

Flu season is raging in the US—and hospitalizations are rising

This year’s flu season is underway in the United States, and the number of cases is rising, according to the latest flu data from the Centers for Disease Control and Prevention (CDC).

M&A mergers and acquisitions business deal

Boston Scientific to acquire Apollo Endosurgery for $615M

Under terms of the deal, Boston Scientific will pay $10 per share to acquire Apollo Endosurgery, well above the company’s previous day’s close of $6 per share.

healthcare value value-based care money dollar

FDA approves world’s most expensive drug, a hemophilia B treatment expected to cost $3.5M

The single-dose gene therapy can help patients reduce their risk of bleeding events and discontinue factor IX prophylaxis therapy.

Health insurance woes: Americans ready to drop coverage if costs keep rising

The Biden-Harris administration helped expand access to health insurance coverage during the COVID-19 pandemic, but rising costs may still cause some Americans to drop insurance coverage altogether.

Kaiser avoids historic nursing strike by boosting pay 22.5%

Kaiser Permanente staved off what would have been the largest private-sector nursing strike after reaching an agreement with 21,000 unionized Northern California nurses.

UnitedHealth, AARP team up for hearing aid savings

UnitedHealthcare has teamed up with AARP to administer hearing aid solutions, including prescription and over-the-counter (OTC) hearing aids.

Iodinated contrast use before, during and after COVID: Trends predict significant growth in demand

A new analysis suggests that, if the use of iodinated contrast were to follow pre-pandemic trends, it could rise by as much as 37% from 2019.

Photo by <a href="https://unsplash.com/@clemono?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Clem Onojeghuo</a> on <a href="https://unsplash.com/s/photos/help-wanted?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText">Unsplash</a>

As recession looms, CEO turnover steadies

CEO turnover leveled out in October after a period marked by a high rate of departures in the healthcare industry.

Economics

ACC raises red flags over telehealth, payment reform and the cardiologist shortage

Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly

Rural hospital switches radiology providers to address lagging wait times

Private equity-backed Medline files for IPO

Medical malpractice reforms appear to curb unnecessary imaging in ED